comparemela.com

Latest Breaking News On - Pericarditis - Page 15 : comparemela.com

Spectrum of CV Effects of Immune Checkpoint Inhibitors Defined

Persistent cardiac symptoms in individuals with mild initial COVID-19

In a recent study published in the journal Nature Medicine, researchers conducted serial cardiac assessments in individuals with mild initial coronavirus disease 2019 (COVID-19) who had no history of cardiac disease and significant comorbidities.

Study: 1 in 100 teens developed heart inflammation after second Pfizer mRNA injection

Recent research conducted in Thailand on 13- to 18-year-olds revealed one out of 100 children have developed heart inflammation after receiving two doses of the Wuhan coronavirus (COVID-19) [.]

U S FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17

Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents can begin once a policy recommendation from the CDC is received GAITHERSBURG, Md., Aug. 22, 2022 /PRNewswire/ Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted(NVX-CoV2373) has received expanded emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a two-dose primary series for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adolescents aged 12 through 17. "Having more vaccine options for use in both adults and adolescents, like the Novavax COVID-19 Vaccine, Adjuvanted will hopefull

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.